Literature DB >> 16858151

The diagnosis of malignancy in effusion cytology: a pattern recognition approach.

Telma C Pereira1, Reda S Saad, Yulin Liu, Jan F Silverman.   

Abstract

This review presents a pattern recognition approach for the diagnosis of malignant effusions. The cytomorphologic features of reactive mesothelial proliferation, mesothelioma and metastatic carcinoma are presented. In addition, the role of ancillary studies in challenging cases and the importance of integrating clinical findings are stressed. An algorithmic approach to the workup of serous effusions as well as pitfalls for false-positive diagnosis are discussed.

Entities:  

Mesh：

Year:  2006        PMID： 16858151     DOI： 10.1097/00125480-200607000-00004

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN： 1072-4109            Impact factor:   3.875


  16 in total

1.  Evaluation of the sensitivity and specificity of immunohistochemical markers in the differential diagnosis of effusion cytology.

Authors:  Zahraa Mohammed Yahya; Hussam Hasson Ali; Haider Ghazi Hussein
Journal:  Oman Med J       Date:  2013-11

Review 2.  Adenocarcinoma cells in effusion cytology as a diagnostic pitfall with potential impact on clinical management: a case report with brief review of immunomarkers.

Authors:  Sinchita Roy Chowdhuri; Patricia Fetsch; Jennifer Squires; Elise Kohn; Armando C Filie
Journal:  Diagn Cytopathol       Date:  2012-11-16       Impact factor: 1.582

3.  Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma.

Authors:  Kiyong Na; Jung-Yun Lee; Ji-Youn Sung; Gun Min Kim; Ja Seung Koo; Hyun-Soo Kim
Journal:  Virchows Arch       Date:  2018-06-20       Impact factor: 4.064

4.  Diagnostic Utility of Epithelial Membrane Antigen (EMA) and Calretinin (CAL) in Effusion Cytology.

Authors:  Neha Nautiyal; Aparna Bhardwaj; Seema Acharya; Sanjeev Kishore; Sandip Kudesia
Journal:  J Clin Diagn Res       Date:  2017-05-01

5.  Claudin 4 identifies a wide spectrum of epithelial neoplasms and represents a very useful marker for carcinoma versus mesothelioma diagnosis in pleural and peritoneal biopsies and effusions.

Authors:  Fabio Facchetti; Silvia Lonardi; Francesca Gentili; Luisa Bercich; Marcella Falchetti; Regina Tardanico; Carla Baronchelli; Laura Lucini; Alessandro Santin; Bruno Murer
Journal:  Virchows Arch       Date:  2007-07-03       Impact factor: 4.064

6.  Utility of a limited panel of calretinin and Ber-EP4 immunocytochemistry on cytospin preparation of serous effusions: A cost-effective measure in resource-limited settings.

Authors:  Raman Arora; Shipra Agarwal; Sandeep R Mathur; Kusum Verma; Venkateswaran K Iyer; Manju Aron
Journal:  Cytojournal       Date:  2011-07-28       Impact factor: 2.091

7.  A review of uncommon cytopathologic diagnoses of pleural effusions from a chest diseases center in Turkey.

Authors:  Ebru Cakir; Funda Demirag; Mehtap Aydin; Yurdanur Erdogan
Journal:  Cytojournal       Date:  2011-07-16       Impact factor: 2.091

8.  Automated ERCC1 immunochemistry on hybrid cytology/tissue microarray of malignant effusions: evaluation of antibodies 8F1 and D-10.

Authors:  Alex Soltermann; Sandra Kilgus-Hawelski; Silvia Behnke; Martina Storz; Holger Moch; Beata Bode
Journal:  J Clin Bioinforma       Date:  2011-09-30

9.  Fine needle aspiration biopsy of metastatic malignant mesothelioma with myxoid change and signet ring cells: A case report and review of the literature.

Authors:  Manisha M Mishra; Carol F Farver; Deborah J Chute
Journal:  Cytojournal       Date:  2016-02-22       Impact factor: 2.091

10.  Diagnostic value of thyroid transcription factor-1 for pleural or other serous metastases of pulmonary adenocarcinoma: a meta-analysis.

Authors:  Yongchun Shen; Caishuang Pang; Konglong Shen; Yanqiu Wu; Diandian Li; Chun Wan; Zenglin Liao; Ting Yang; Lei Chen; Fuqiang Wen
Journal:  Sci Rep       Date:  2016-01-25       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.